Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Traditional Chinese medicine composition for treating liver-qi stagnation type hyperthyroidism complicating automatic atrial tachycardia

A technology for atrial tachycardia and liver qi stagnation, applied in the field of medicine, can solve the problems of incompletely clear pathogenesis, difficult relief of symptoms, easy recurrence, etc., to restore the level of thyroid function, have no effect on safety indicators, and improve clinical symptoms Effect

Inactive Publication Date: 2016-06-22
JINAN BANGWEN MEDICAL TECH
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Hyperthyroid arrhythmia is prone to misdiagnosis, missed diagnosis, and delayed treatment. The treatment cycle of this disease is long, the symptoms are not easy to relieve, and it is easy to relapse. If the treatment is improper or delayed, it will cause great damage to the heart structure and physiological functions, and even produce irreversible heart disease
[0003] At present, the pathogenesis of hyperthyroidism combined with automatic atrial tachycardia is still not fully understood by Western medicine, and there is no effective treatment for it.
[0004] Liver Qi stagnation type is a common type of hyperthyroidism combined with spontaneous atrial tachycardia, and there is no drug dedicated to this type of hyperthyroidism combined with spontaneous atrial tachycardia

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] A traditional Chinese medicine composition for treating liver qi stagnation type hyperthyroidism combined with spontaneous atrial tachycardia, the weight ratio of each raw material is as follows:

[0040] Lathyrus 6g, Ruyuan magnolia 6g, mountain bark 6g, salsa 6g, sedge 6g, frangipani 6g, fragrant osmanthus 6g, japonica 6g, lip vanilla 6g, august leaves 6g, variegated orchid 6g, licorice 6g.

Embodiment 2

[0042] A traditional Chinese medicine composition for treating liver qi stagnation type hyperthyroidism combined with spontaneous atrial tachycardia, the weight ratio of each raw material is as follows:

[0043]Lathyrus 5g, Ruyuan magnolia 7g, mountain bark 5g, sedge 7g, sedge 5g, frangipani 7g, osmanthus fragrans 5g, snake vine fruit 7g, lip vanilla 5g, August leaves 7g, variegated orchid 5g, licorice 7g.

Embodiment 3

[0045] A traditional Chinese medicine composition for treating liver qi stagnation type hyperthyroidism combined with spontaneous atrial tachycardia, the weight ratio of each raw material is as follows:

[0046] Lathyrus 7g, Ruyuan Magnolia 5g, Mountain Pitt 7g, Salsa 5g, Sedge 7g, Frangipani 5g, Fragrant Osmanthus 7g, Echinopsis japonica 5g, Lip Vanilla 7g, August Zha 5g, variegated orchid 7g, licorice 5g.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of medicine and particularly relates to a traditional Chinese medicine composition for treating liver-qi stagnation type hyperthyroidism complicating automatic atrial tachycardia. The traditional Chinese medicine composition is prepared from, by weight, 4-8 parts of all grass of David vetchling, 4-8 parts of manglietia yuyuanensis fruits, 4-8 parts of roots of Szechwan indigo, 4-8 parts of semen aesculi, 4-8 parts of herb of nutgrass galingale, 4-8 parts of jasminum officinale flowers, 4-8 parts of roots and fruits of sarcococca ruscifolia stapf, 4-8 parts of celastrus flagellaris Rupr. fruits, 4-8 parts of all grass of ziziphora clinopodioides Lam., 4-8 parts of fiveleaf akebia fruits, 4-8 parts of herb of creeping rattlesnake plantain and 4-8 parts of liquorice roots. All the medicinal materials are combined to jointly achieve the effects of soothing liver-qi stagnation, regulating qi to loosen the center, resolving hardness to dissipate stagnation, and tranquilizing the mind by soothing the heart. The average heart rate can be reduced, the thyroid function level can be recovered, the safety index is not affected, and safety is good.

Description

technical field [0001] The invention belongs to the technical field of medicines, and in particular relates to a traditional Chinese medicine composition for treating liver-qi stagnation type hyperthyroidism combined with autonomous atrial tachycardia. Background technique [0002] Hyperthyroidism can lead to the occurrence of different arrhythmias. Arrhythmia is sometimes even the earliest symptoms and signs when seeing a doctor. Most patients see a doctor with arrhythmia as the first symptom. The patient is a tachyarrhythmia. Atrial fibrillation is the most common type. Hyperthyroid arrhythmia is prone to misdiagnosis, missed diagnosis, and delayed treatment. The treatment cycle of this disease is long, the symptoms are not easy to relieve, and it is easy to relapse. If the treatment is improper or delayed, it will cause great damage to the heart structure and physiological functions, and even produce Irreversible heart disease. [0003] At present, the pathogenesis of h...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/898A61P5/16A61P9/06
CPCA61K36/185A61K36/37A61K36/48A61K36/484A61K36/53A61K36/57A61K36/63A61K36/8905A61K36/898A61K2300/00
Inventor 不公告发明人
Owner JINAN BANGWEN MEDICAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products